MERCAPTOIMIDAZOLINE--PROHIBITED
General Information
Mainterm | MERCAPTOIMIDAZOLINE--PROHIBITED |
CAS Reg.No.(or other ID) | 96-45-7 |
Regnum |
189.250 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 2723650 |
IUPAC Name | imidazolidine-2-thione |
InChI | InChI=1S/C3H6N2S/c6-3-4-1-2-5-3/h1-2H2,(H2,4,5,6) |
InChI Key | PDQAZBWRQCGBEV-UHFFFAOYSA-N |
Canonical SMILES | C1CNC(=S)N1 |
Molecular Formula | C3H6N2S |
Wikipedia | 2-mercaptoimidazoline |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 102.155 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 0 |
Complexity | 63.2 |
CACTVS Substructure Key Fingerprint | A A A D c Y B D A A B A A A A A A A A A A A A A A A A A A W A A A A A A A A A A A A A A A A A A A A A A H A Q Q A A A A A A D B A A Q B A A L A A A A E A A A A A A A A A A A A A A k A A I A I A A C A Q A A A A A A Q A A A I E A I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 56.2 |
Monoisotopic Mass | 102.025 |
Exact Mass | 102.025 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 6 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9493 |
Human Intestinal Absorption | HIA+ | 0.5082 |
Caco-2 Permeability | Caco2- | 0.5181 |
P-glycoprotein Substrate | Substrate | 0.5000 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9440 |
Non-inhibitor | 0.9951 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.6141 |
Distribution | ||
Subcellular localization | Lysosome | 0.6804 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8726 |
CYP450 2D6 Substrate | Non-substrate | 0.7219 |
CYP450 3A4 Substrate | Non-substrate | 0.8007 |
CYP450 1A2 Inhibitor | Inhibitor | 0.6332 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.6968 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.5266 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6330 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6674 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9154 |
Non-inhibitor | 0.9214 | |
AMES Toxicity | AMES toxic | 0.9108 |
Carcinogens | Non-carcinogens | 0.9564 |
Fish Toxicity | High FHMT | 0.5859 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8189 |
Honey Bee Toxicity | Low HBT | 0.5377 |
Biodegradation | Not ready biodegradable | 0.9319 |
Acute Oral Toxicity | III | 0.8060 |
Carcinogenicity (Three-class) | Danger | 0.7463 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -0.7724 | LogS |
Caco-2 Permeability | 0.9373 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.7774 | LD50, mol/kg |
Fish Toxicity | 2.6993 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.5409 | pIGC50, ug/L |
From admetSAR
Toxicity Profile
Route of Exposure | None |
---|---|
Mechanism of Toxicity | None |
Metabolism | None |
Toxicity Values | None |
Lethal Dose | None |
Carcinogenicity (IARC Classification) | 3, not classifiable as to its carcinogenicity to humans. |
Minimum Risk Level | None |
Health Effects | None |
Treatment | None |
Reference |
|
From T3DB
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organoheterocyclic compounds |
Class | Azolidines |
Subclass | Imidazolidines |
Intermediate Tree Nodes | Not available |
Direct Parent | Imidazolidines |
Alternative Parents | |
Molecular Framework | Aliphatic heteromonocyclic compounds |
Substituents | Imidazolidine - Thiourea - Azacycle - Organic nitrogen compound - Organopnictogen compound - Hydrocarbon derivative - Organosulfur compound - Organonitrogen compound - Aliphatic heteromonocyclic compound |
Description | This compound belongs to the class of organic compounds known as imidazolidines. These are organic compounds containing an imidazolidine ring, which is a saturated ring (derived from imidazole) with two nitrogen atoms at positions 1 and 3 respectively, and containing only single bonds. |
From ClassyFire
Targets
- General Function:
- Transferase activity
- Specific Function:
- Synthesizes the second messagers cyclic ADP-ribose and nicotinate-adenine dinucleotide phosphate, the former a second messenger for glucose-induced insulin secretion. Also has cADPr hydrolase activity. Also moonlights as a receptor in cells of the immune system.
- Gene Name:
- CD38
- Uniprot ID:
- P28907
- Molecular Weight:
- 34328.145 Da
References
- Sipes NS, Martin MT, Kothiya P, Reif DM, Judson RS, Richard AM, Houck KA, Dix DJ, Kavlock RJ, Knudsen TB: Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol. 2013 Jun 17;26(6):878-95. doi: 10.1021/tx400021f. Epub 2013 May 16. [23611293 ]
- General Function:
- Urokinase plasminogen activator receptor activity
- Specific Function:
- Acts as a receptor for urokinase plasminogen activator. Plays a role in localizing and promoting plasmin formation. Mediates the proteolysis-independent signal transduction activation effects of U-PA. It is subject to negative-feedback regulation by U-PA which cleaves it into an inactive form.
- Gene Name:
- PLAUR
- Uniprot ID:
- Q03405
- Molecular Weight:
- 36977.62 Da
References
- Sipes NS, Martin MT, Kothiya P, Reif DM, Judson RS, Richard AM, Houck KA, Dix DJ, Kavlock RJ, Knudsen TB: Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol. 2013 Jun 17;26(6):878-95. doi: 10.1021/tx400021f. Epub 2013 May 16. [23611293 ]
From T3DB